Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 3—March 2016

Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India

Kerry L. Dierberg, Kunchok Dorjee, Fulvio Salvo, Wendy A. Cronin, J’Belle Boddy, Daniela Cirillo, Tsetan Sadutshang, and Richard E. ChaissonComments to Author 
Author affiliations: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA (K.L. Dierberg, J.’B. Boddy, R.E. Chaisson); Tibetan Delek Hospital, Dharamsala, India (K. Dorjee, T. Sadutshang); Central Tibetan Administration Department of Health, Dharamsala (K. Dorjee, T. Sadutshang); San Raffaele Scientific Institute, Milan, Italy (F. Salvo, D. Cirillo); Maryland Department of Health and Mental Hygiene, Baltimore (W.A. Cronin)

Main Article

Table 1

Characteristics of 3,830 Tibetan refugees in India screened for tuberculosis*

Characteristic No. (%)
M 2,464 (64.3)
F 1,366 (35.7)
Age, y
<18 1,633 (42.6)
18–24 1,363 (35.6)
25–34 529 (13.8)
35–44 194 (5.1)
45–54 53 (1.4)
>55 58 (1.5)
Enrollment group
Students 2,118 (55.3)
Monks/nuns 1,155 (30.2)
Reception center personnel 438 (11.4)
Other (community members, contacts) 73 (1.9)
Tibetan 3,585 (93.6)
Other (India, Nepal, Bhutan, Mongolia) 245 (6.4)
Risk factors
History of TB 391 (10.2)
Any history of TB contact 2,221 (58.0)
Recent close TB contact (<6 mo) 1,883 (49.2)
No known TB contact 1,609 (42.0)

*TB, tuberculosis.

Main Article

Page created: February 17, 2016
Page updated: February 17, 2016
Page reviewed: February 17, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.